Actions

CD38: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 36: Line 36:
|}
|}


<span style="font-size:90%">'''Notes:''' In aml CD14 expression defines monocytic lineage restriction but may be absent especially in more primitive monoblastic cases   </span>
<span style="font-size:90%">'''Notes:''' ''*'' low expression correlates with subtype e.g. APML   </span>





Revision as of 10:25, 8 May 2023



DETAILS

CD38 helps mobilise intracellular calcium to activate a wide array of cell functions. In haematological cell types CD38 it is widely expressed by lymphoid cells )B, T and NK) as well as myeloid precursor cells and mature myeloid cells. It has particular diagnostic importance for lymphocytes where CD38 expression is acquired as stem cells commit to B-cell lineage, then is lost as mature B cells emerge from bone marrow before being re-acquired at the time of plasma cell differentiation.


What is its diagnostic role?

The wide expression of CD38 limits its diagnostic value except in very specific circumstances:

  • The co-expression of CD38 with CD138 can identify normal or neoplastic plasma cells
  • Expression of CD38 in chronic lymphocytic leukaemia (>20% of cells) may associated with poorer outcome


Other relevant information: CD38 is a therapeutic target, daratumumab is a monoclonal antibody which binds to CD38 and is used in the treatment of myeloma.



Expression in primitive cell types
AML CMML B ALL Burkitt T ALL ETP ALL <I> MPAL <I> Hgns <I>
2-20%* 80-100% <5% <5% <5% <5% <5% <5%

Notes: * low expression correlates with subtype e.g. APML


Expression in mature B cell neoplasms
CLL MCL FL MZL HCL DLBCL LPL PCL
<5% <5% <5% <5% <5% <5% <5% <5%

Notes: Low level expression has been reported on activated lymphocytes, but it has no definite diagnostic role


Expression in mature T cell neoplasms
ATLL CTCL/Sezary T-PLL T-LGL NK-LGL
<5% <5% <5% <5% <5%




SUMMARY TABLES

Expression of CD38 by primitive lymphoid cells: ALL and haematogones
pro-B ALL early pre-B ALL pre-B ALL B-ALL pro-T ALL mature-T ALL AML Haematogones
* stg

* low expression correlates with subtype e.g. APML

Expression of CD38 by mature B cells: B-lymphoproliferative disorders
CLL MCL FL HCL HCv MZL LPL PCL
* ** stg/mod

*May indicate adverse prognostic when present on more than 20% of cells

**May be weak


1. Colour key: - the likelihood of any individual case expressing this marker, indicated by colour:

Rare (<5%) Possible (5-20%) Likely (20-40%) Frequent (40-80%) Expected (80-100%)

2. Text key: - where expression level is characteristic of a disorder this is indicated by text:

abs = absent expression, wk = weak expression, mod = moderate expression, stg = strong expression, sub = expression may be on a sub-population of cells